Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib.

British journal of haematology - 1 Apr 2013

Follows George A, Sims Hannah, Bloxham David M, Zenz Thorsten, Hopper Melanie A, Liu Hongxiang, Bench Anthony, Wright Penny, Van't Veer Mars B, Scott Mike A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antineoplastic Agents
Share to Drug Administration Schedule
Share to Indoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Hairy Cell

Share to Proto-Oncogene Proteins B-raf

Share to Sulfonamides

Share to Vemurafenib

Source

Identifiers

PMID: 23278307
DOI: 10.1111/bjh.12201

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib.PMID 23278307Read ↗

Rapid response to vemurafenib in a heavily pretreated patient with hairy cell leukemia and a BRAF mutation.Semantic proximity Read ↗

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.Semantic proximity Read ↗

Efficacy of vemurafenib in hairy-cell leukemia.Semantic proximity Read ↗

BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials.Semantic proximity Read ↗

Targetable Mutations in BRAF V600E–Negative Hairy-Cell LeukemiaSemantic proximity Read ↗

BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activitySemantic proximity Read ↗

BRAF V600E mutation in hairy cell leukemia: from bench to bedsideSemantic proximity Read ↗

BRAF inhibition in refractory hairy-cell leukemia.Semantic proximity Read ↗

Genomics of Hairy Cell LeukemiaSemantic proximity Read ↗

Hairy Cell Leukaemia.Semantic proximity Read ↗

Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia.Semantic proximity Read ↗

Non-V600E BRAF mutations and treatment for hairy cell leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.